Skip to main content

Chemfab Alkalis Ltd

NSE: CHEMFAB BSE: 541269

Incorproated in 2009, Chemfab Alkalis Ltd manufactures basic inorganic chemicals and PVCO pipes[1]

437
52W: ₹270 — ₹880
PE 83.6 · Book ₹288 · +52% vs book
Market Cap₹628 Cr
Stock P/E83.6Price to Earnings
ROCE3.54%Return on Capital
ROE1.83%Return on Equity
Div. Yield0.29%Face Value ₹10

Weaknesses

  • The company has delivered a poor sales growth of 9.80% over past five years.
  • Company has a low return on equity of 4.38% over last 3 years.
  • Dividend payout has been low at 13.9% of profits over last 3 years

Shareholding Pattern

Promoters72.14%
FIIs0.04%
DIIs0.1%
Public27.64%
CategoryJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters72.88%72.63%0.372.56%0.172.18%0.472.18%72.18%72.14%0.072.14%
FIIs0.27%0.11%0.20.03%0.10.03%0.01%0.00%0.00.08%0.10.04%0.0
DIIs0.07%0.07%0.27%0.20.27%0.27%0.27%0.22%0.10.1%0.1
Public26.77%27.2%0.427.12%0.127.5%0.427.53%0.027.48%0.127.49%0.027.64%0.2

Financial Statements

MetricDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales86.3382.376.047979.2187.8587.5870.4161.8568.73
Expenses69.9469.1365.5966.3464.7272.1674.1661.9756.6861.36
Operating Profit16.3913.1710.4512.6614.4915.6913.428.445.177.37
OPM %18.99%16%13.74%16.03%18.29%17.86%15.32%11.99%8.36%10.72%
Net Profit8.166.564.332.954.023.935.391.59-1.041.56
EPS ₹5.744.613.032.062.812.743.751.11-0.721.09

AI Insights

Revenue Trend

Mar 2026 revenue at ₹289Cr, down 10.2% YoY. OPM at 12%.

Debt Position

Borrowings at ₹126Cr. Debt-to-equity ratio: 0.32x. Healthy balance sheet.

Capex Cycle

CWIP at ₹28Cr (9% of fixed assets). Moderate ongoing capital expenditure.

Institutional Flow

DIIs: 0.1% (+0.03pp change). FIIs: 0.04% (-0.24pp change). Promoters hold 72.14%.

Margin & Efficiency

ROCE improving from 0% (Mar 2015) to 4% (Mar 2026). Working capital days: -39.

Valuation

PE 83.6x with 3.54% ROCE. Price is 52% above book value of ₹288. Dividend yield: 0.29%.

Recent Announcements